"TBSF" Human Immunoglobulin for Intravenous Use

البلد: أستراليا

اللغة: الإنجليزية

المصدر: Department of Health (Therapeutic Goods Administration)

العنصر النشط:

normal immunoglobulin, Quantity: 60 g/L

متاح من:

CSL Behring Australia Pty Ltd

INN (الاسم الدولي):

normal immunoglobulin

الشكل الصيدلاني:

Injection, solution

تركيب:

Excipient Ingredients: maltose

طريقة التعاطي:

Intravenous

الوحدات في الحزمة:

50mL, 200mL

الفئة:

Medicine Listed (Export Only)

نوع الوصفة الطبية :

(S1) This Schedule is intentionally blank

الخصائص العلاجية:

TBSF Human Immunoglobulin for Intravenous Use is indicated for replacement IgG therapy in: * primary immunodeficiency (PID) * symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. TBSF Human Immunoglobulin for Intravenous Use is indicated for immunomodulatory therapy in: * Idiopathic Thrombocytopenic Purpura (ITP), in adults or children at high risk of bleeding or prior to surgery to correct the platelet count * allogeneic bone marrow transplantation * Kawasaki disease * Guillain-Barre Syndrome (GBS).

ملخص المنتج:

Visual Identification: Clear, colourless solution; Container Type: Vial; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

الوضع إذن:

Listed (Export Only)

تاريخ الترخيص:

2006-03-01